Last updated: 2026-09-16 09:46:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Palatin Technologies, Inc. (PTN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10.84, with a market capitalisation of $23.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.21 to $31.00. This page covers its latest market performance, valuation, price trends and company information.
$23.77M | |
$11.14 | |
$1,472.50 | |
$0.09 | |
$10.94 | |
-- | |
60.36K | |
-- | |
$31.00 | |
$7.21 | |
-- | |
-- |
Palatin Technologies, Inc. (PTN) is trading at $10.84 in pre-market trading as of 2026-09-16 08:05:00, down 0.96% ($0.10) from the previous close of $10.94
Pre-market trading shows how investors are pricing PTN before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Palatin Technologies, Inc. (PTN) moved from $12.70 to $10.84, representing a decline of 14.69% ($1.86).
The stock traded between $10.77 and $13.78 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 190.14 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 15.2%
PTN is currently trading at $10.84, placing it 15.2% of the way from its 52-week low of $7.21 to its 52-week high of $31.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 29 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Palatin Technologies, Inc. (PTN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.